ESR1 and breast carcinoma: Approximately 20% to 40% of patients with breast cancer eventually relapse in distant organs (i.e., metastasis), which remain undetectable for years after primary tumor diagnosis, and this phenomenon is commonly observed in ERα-positive breast cancer.